Jemima Monchery is a clinical trial manager at Neurvati Neurosciences and GRIN Therapeutics. She has experience in clinical operations management for both domestic and global studies including working at the site level and with full-service CROs and trial sponsors in areas including oncology, neurology, and rare disease. She began her career at Yale Cancer Center, coordinating early and late phase lung oncology clinical studies. She progressed into biotechnology with a role at Roche, working as a member of the Pharma Research Early Development team working on global clinical trials. She then progressed to leadership roles in the CRO sector, executing end-to-end clinical project management including strategies to improve operational efficiencies. Most recently, Jemima worked at Alexion Pharmaceuticals where she was responsible for execution of operational plans and strategies for a Phase 4 interventional pediatric rare disease study and a neuro observational global registry. She received her BS in biology from Providence College and her MHS in biomedical science from Quinnipiac University.